Influenza virus internal and matrix proteins (M/NP/Pol)

The internal and matrix proteins of the influenza virus, including Matrix 1 (M1), Matrix 2 (M2), Nucleoprotein (NP), and the polymerase complex (PA, PB1, PB2), are highly conserved components essential for the viral life cycle (Sridhar, 2015). Unlike the surface glycoproteins hemagglutinin and neuraminidase, which undergo frequent antigenic drift, these internal proteins remain relatively stable across different strains, making them primary targets for universal vaccine development and broad-spectrum antivirals (Portela & Digard, 2002). The M1 protein provides structural support and facilitates the nuclear export of viral ribonucleoproteins, while the M2 protein acts as a proton-selective ion channel required for viral uncoating and assembly (Pinto et al., 1992; Zhang et al., 2012). The NP protein coats the viral RNA segments, and the polymerase complex is responsible for viral genome replication and transcription (Portela & Digard, 2002). Current therapeutic strategies include M2 blockers like amantadine and polymerase inhibitors like baloxavir marboxil, although the clinical utility of M2 blockers is currently limited by widespread viral resistance (CDC, 2023).

Other names

Influenza internal proteinsMatrix and nucleoproteinsConserved influenza antigensM1, M2, NP, and Polymerase complex

Inhibition of the M2 ion channel to prevent viral uncoating; inhibition of the PA subunit endonuclease to block viral mRNA transcription; inhibition of the PB1 subunit to prevent RNA synthesis; and stabilization of NP to prevent ribonucleoprotein assembly.